Venetoclax + Obinutuzumab

Treatment used for 1 condition

Total Trials
45
Total Participants
6K
Avg Effectiveness
92%
Avg Safety Score
38%

Conditions Treated

Click on a condition to view detailed treatment information and clinical trial data.